USE OF ULTRASOUND SCREENING IN THE DIAGNOSIS OF INTRADUCTAL BREAST LESIONS

Currently, the only way to reduce breast cancer mortality is through early diagnosis, which enables the detection of cancer at the earliest preclinical stages of development. A wide range of available tests, including ultrasound, elastography, mammography (ductography), CA-15.6 tumor marker testing, and biopsy followed by histological and immunohistochemical examination, creates the preconditions for the early detection of pathological processes.